The Bioabsorbables/Bioresorbables Center

Filter Your Results

 

News

 

Enrollment Concluded for EVOLVE II Trial of Boston Scientific’s Synergy Stent System

September 12, 2013 -- Boston Scientific Corporation (Natick, MA) announced it has completed enrollment in the EVOLVE II randomized, controlled clinical trial of the Syner…

Boston Scientific Presents Data Supporting Promus Premier and Synergy DES

May 22, 2013 -- At EuroPCR 2013 in Paris, Boston Scientific Corporation (Natick, MA) reported positive results from the NG PROMUS and the EVOLVE trials, which are evaluating n…

Innovations

January/February 2013—Synergy Coronary Stent System Company Boston Scientific Corporation Phone N/A Web www.bostonscientificinternational. com/home.bsci Key Features Ultrathin, ablumina…

Boston Scientific Begins EVOLVE II Study of Bioabsorbable Synergy Drug-Eluting Stent

November 30, 2012 -- Boston Scientific Corporation (Natick, MA) announced that the first patient has been enrolled in the EVOLVE II clinical trial, which is designed to …

Boston Scientific Gains CE Mark Approval for Synergy DES With Bioabsorbable Polymer

October 31, 2012 -- Boston Scientific Corporation (Natick, MA) announced that it has received CE Mark approval for the Synergy everolimus-eluting platinum chromium (PtCr) coro…

European Labeling Update Approved for 3-Month DAPT for Boston Scientific’s Promus Element and Promus Element Plus

October 24, 2012 -- Boston Scientific Corporation (Natick, MA) announced that it has received European CE Mark approval to update the directions-for-use labeling for the Promu…

Boston Scientific Presents EVOLVE Data for Next-Generation Synergy PtCr DES

May 15, 2012 -- Boston Scientific Corporation (Natick, MA) announced the presentation of data from the EVOLVE clinical trial of the company’s Synergy drug-eluting c…

EVOLVE Data Presented for Boston Scientific’s Synergy Bioabsorbable DES

November 11, 2011 -- Boston Scientific Corporation (Natick, MA) announced that results from the EVOLVE first-human-use trial demonstrated the noninferiority of the company&rsq…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.